カテゴリー： 世界, 医療/バイオ, LP Information

世界の経口利尿薬市場予測 2023年-2029年

【英語タイトル】Global Oral Diuretic Drugs Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC06150）・商品コード：LP23DC06150
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：103
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の経口利尿薬市場」は、過去の販売実績から2022年の世界の経口利尿薬の総販売量を検討し、2023年から2029年の予測される経口利尿薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の経口利尿薬の市場規模を掲載し、XXX百万米ドル規模の世界の経口利尿薬市場の詳細な分析を提供します。本インサイトレポートは、世界の経口利尿薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の経口利尿薬市場における各社の独自のポジションをより深く理解するために、経口利尿薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の経口利尿薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。経口利尿薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。経口利尿薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。経口利尿薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

経口利尿薬の世界主要メーカーとしては、AstraZeneca、 Aurobindo Pharma、 Bayer AG、 Bristol-Myers Squibb Company、 Cipla Ltd、 F. Hoffmann-La Roche、 Fresenius Kabi、 GSK、 Hikma Pharmaceuticals、 Mylan、 Novartis Pharmaceuticals、 Pfizer、 Sanofi、 Teva Pharmaceutical Industriesなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の経口利尿薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では経口利尿薬市場をセグメンテーションし、種類別 (ループ利尿薬、チアジド系利尿薬、炭酸脱水酵素阻害薬、カリウム保持性利尿薬、浸透圧利尿薬)、用途別 (病院薬局、小売薬局、オンライン薬局)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：ループ利尿薬、チアジド系利尿薬、炭酸脱水酵素阻害薬、カリウム保持性利尿薬、浸透圧利尿薬

・用途別区分：病院薬局、小売薬局、オンライン薬局

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の経口利尿薬市場の10年間の市場状況・展望は？
・世界および地域別に見た経口利尿薬市場成長の要因は何か？
・経口利尿薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・経口利尿薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：経口利尿薬の年間販売量2018-2029、地域別現状・将来分析
・経口利尿薬の種類別セグメント：ループ利尿薬、チアジド系利尿薬、炭酸脱水酵素阻害薬、カリウム保持性利尿薬、浸透圧利尿薬
・経口利尿薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・経口利尿薬の用途別セグメント：病院薬局、小売薬局、オンライン薬局
・経口利尿薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の経口利尿薬市場
・企業別のグローバル経口利尿薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別の経口利尿薬の年間売上：2018-2023年の売上、市場シェア
・企業別の経口利尿薬販売価格
・主要企業の経口利尿薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

経口利尿薬の地域別レビュー
・地域別の経口利尿薬市場規模2018-2023：年間販売量、売上
・主要国別の経口利尿薬市場規模2018-2023：年間販売量、売上
・南北アメリカの経口利尿薬販売の成長
・アジア太平洋の経口利尿薬販売の成長
・ヨーロッパの経口利尿薬販売の成長
・中東・アフリカの経口利尿薬販売の成長

南北アメリカ市場
・南北アメリカの国別の経口利尿薬販売量、売上（2018-2023）
・南北アメリカの経口利尿薬の種類別販売量
・南北アメリカの経口利尿薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の経口利尿薬販売量、売上（2018-2023）
・アジア太平洋の経口利尿薬の種類別販売量
・アジア太平洋の経口利尿薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の経口利尿薬販売量、売上（2018-2023）
・ヨーロッパの経口利尿薬の種類別販売量
・ヨーロッパの経口利尿薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の経口利尿薬販売量、売上（2018-2023）
・中東・アフリカの経口利尿薬の種類別販売量
・中東・アフリカの経口利尿薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・経口利尿薬の製造コスト構造分析
・経口利尿薬の製造プロセス分析
・経口利尿薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・経口利尿薬の主要なグローバル販売業者
・経口利尿薬の主要なグローバル顧客

地域別の経口利尿薬市場予測レビュー
・地域別の経口利尿薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・経口利尿薬の種類別市場規模予測
・経口利尿薬の用途別市場規模予測

主要企業分析
AstraZeneca、 Aurobindo Pharma、 Bayer AG、 Bristol-Myers Squibb Company、 Cipla Ltd、 F. Hoffmann-La Roche、 Fresenius Kabi、 GSK、 Hikma Pharmaceuticals、 Mylan、 Novartis Pharmaceuticals、 Pfizer、 Sanofi、 Teva Pharmaceutical Industries
・企業情報
・経口利尿薬製品
・経口利尿薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Oral Diuretic Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Oral Diuretic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oral Diuretic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oral Diuretic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oral Diuretic Drugs players cover AstraZeneca, Aurobindo Pharma, Bayer AG, Bristol-Myers Squibb Company, Cipla Ltd, F. Hoffmann-La Roche, Fresenius Kabi, GSK and Hikma Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Oral Diuretic Drugs Industry Forecast” looks at past sales and reviews total world Oral Diuretic Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Oral Diuretic Drugs sales for 2023 through 2029. With Oral Diuretic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Diuretic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Oral Diuretic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Diuretic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Diuretic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Diuretic Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Diuretic Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Diuretic Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Loop Diuretics
Thiazides and Thiazide-Like Diuretics
Carbonic Anhydrase Inhibitors
Potassium-Sparing Diuretics
Osmotic Diuretics
Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
AstraZeneca
Aurobindo Pharma
Bayer AG
Bristol-Myers Squibb Company
Cipla Ltd
F. Hoffmann-La Roche
Fresenius Kabi
GSK
Hikma Pharmaceuticals
Mylan
Novartis Pharmaceuticals
Pfizer
Sanofi
Teva Pharmaceutical Industries
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oral Diuretic Drugs market?
What factors are driving Oral Diuretic Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Diuretic Drugs market opportunities vary by end market size?
How does Oral Diuretic Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Diuretic Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Oral Diuretic Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Oral Diuretic Drugs by Country/Region, 2018, 2022 & 2029
2.2 Oral Diuretic Drugs Segment by Type
2.2.1 Loop Diuretics
2.2.2 Thiazides and Thiazide-Like Diuretics
2.2.3 Carbonic Anhydrase Inhibitors
2.2.4 Potassium-Sparing Diuretics
2.2.5 Osmotic Diuretics
2.3 Oral Diuretic Drugs Sales by Type
2.3.1 Global Oral Diuretic Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Oral Diuretic Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Oral Diuretic Drugs Sale Price by Type (2018-2023)
2.4 Oral Diuretic Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Oral Diuretic Drugs Sales by Application
2.5.1 Global Oral Diuretic Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Oral Diuretic Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Oral Diuretic Drugs Sale Price by Application (2018-2023)
3 Global Oral Diuretic Drugs by Company
3.1 Global Oral Diuretic Drugs Breakdown Data by Company
3.1.1 Global Oral Diuretic Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Oral Diuretic Drugs Sales Market Share by Company (2018-2023)
3.2 Global Oral Diuretic Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Oral Diuretic Drugs Revenue by Company (2018-2023)
3.2.2 Global Oral Diuretic Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Oral Diuretic Drugs Sale Price by Company
3.4 Key Manufacturers Oral Diuretic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Diuretic Drugs Product Location Distribution
3.4.2 Players Oral Diuretic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral Diuretic Drugs by Geographic Region
4.1 World Historic Oral Diuretic Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Oral Diuretic Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Oral Diuretic Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Oral Diuretic Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Oral Diuretic Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Oral Diuretic Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Oral Diuretic Drugs Sales Growth
4.4 APAC Oral Diuretic Drugs Sales Growth
4.5 Europe Oral Diuretic Drugs Sales Growth
4.6 Middle East & Africa Oral Diuretic Drugs Sales Growth
5 Americas
5.1 Americas Oral Diuretic Drugs Sales by Country
5.1.1 Americas Oral Diuretic Drugs Sales by Country (2018-2023)
5.1.2 Americas Oral Diuretic Drugs Revenue by Country (2018-2023)
5.2 Americas Oral Diuretic Drugs Sales by Type
5.3 Americas Oral Diuretic Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Diuretic Drugs Sales by Region
6.1.1 APAC Oral Diuretic Drugs Sales by Region (2018-2023)
6.1.2 APAC Oral Diuretic Drugs Revenue by Region (2018-2023)
6.2 APAC Oral Diuretic Drugs Sales by Type
6.3 APAC Oral Diuretic Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Diuretic Drugs by Country
7.1.1 Europe Oral Diuretic Drugs Sales by Country (2018-2023)
7.1.2 Europe Oral Diuretic Drugs Revenue by Country (2018-2023)
7.2 Europe Oral Diuretic Drugs Sales by Type
7.3 Europe Oral Diuretic Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Diuretic Drugs by Country
8.1.1 Middle East & Africa Oral Diuretic Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Oral Diuretic Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Oral Diuretic Drugs Sales by Type
8.3 Middle East & Africa Oral Diuretic Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Diuretic Drugs
10.3 Manufacturing Process Analysis of Oral Diuretic Drugs
10.4 Industry Chain Structure of Oral Diuretic Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Diuretic Drugs Distributors
11.3 Oral Diuretic Drugs Customer
12 World Forecast Review for Oral Diuretic Drugs by Geographic Region
12.1 Global Oral Diuretic Drugs Market Size Forecast by Region
12.1.1 Global Oral Diuretic Drugs Forecast by Region (2024-2029)
12.1.2 Global Oral Diuretic Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Diuretic Drugs Forecast by Type
12.7 Global Oral Diuretic Drugs Forecast by Application
13 Key Players Analysis
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Oral Diuretic Drugs Product Portfolios and Specifications
13.1.3 AstraZeneca Oral Diuretic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Aurobindo Pharma
13.2.1 Aurobindo Pharma Company Information
13.2.2 Aurobindo Pharma Oral Diuretic Drugs Product Portfolios and Specifications
13.2.3 Aurobindo Pharma Oral Diuretic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Aurobindo Pharma Main Business Overview
13.2.5 Aurobindo Pharma Latest Developments
13.3 Bayer AG
13.3.1 Bayer AG Company Information
13.3.2 Bayer AG Oral Diuretic Drugs Product Portfolios and Specifications
13.3.3 Bayer AG Oral Diuretic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bayer AG Main Business Overview
13.3.5 Bayer AG Latest Developments
13.4 Bristol-Myers Squibb Company
13.4.1 Bristol-Myers Squibb Company Company Information
13.4.2 Bristol-Myers Squibb Company Oral Diuretic Drugs Product Portfolios and Specifications
13.4.3 Bristol-Myers Squibb Company Oral Diuretic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bristol-Myers Squibb Company Main Business Overview
13.4.5 Bristol-Myers Squibb Company Latest Developments
13.5 Cipla Ltd
13.5.1 Cipla Ltd Company Information
13.5.2 Cipla Ltd Oral Diuretic Drugs Product Portfolios and Specifications
13.5.3 Cipla Ltd Oral Diuretic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cipla Ltd Main Business Overview
13.5.5 Cipla Ltd Latest Developments
13.6 F. Hoffmann-La Roche
13.6.1 F. Hoffmann-La Roche Company Information
13.6.2 F. Hoffmann-La Roche Oral Diuretic Drugs Product Portfolios and Specifications
13.6.3 F. Hoffmann-La Roche Oral Diuretic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 F. Hoffmann-La Roche Main Business Overview
13.6.5 F. Hoffmann-La Roche Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Oral Diuretic Drugs Product Portfolios and Specifications
13.7.3 Fresenius Kabi Oral Diuretic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 GSK
13.8.1 GSK Company Information
13.8.2 GSK Oral Diuretic Drugs Product Portfolios and Specifications
13.8.3 GSK Oral Diuretic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 GSK Main Business Overview
13.8.5 GSK Latest Developments
13.9 Hikma Pharmaceuticals
13.9.1 Hikma Pharmaceuticals Company Information
13.9.2 Hikma Pharmaceuticals Oral Diuretic Drugs Product Portfolios and Specifications
13.9.3 Hikma Pharmaceuticals Oral Diuretic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hikma Pharmaceuticals Main Business Overview
13.9.5 Hikma Pharmaceuticals Latest Developments
13.10 Mylan
13.10.1 Mylan Company Information
13.10.2 Mylan Oral Diuretic Drugs Product Portfolios and Specifications
13.10.3 Mylan Oral Diuretic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Mylan Main Business Overview
13.10.5 Mylan Latest Developments
13.11 Novartis Pharmaceuticals
13.11.1 Novartis Pharmaceuticals Company Information
13.11.2 Novartis Pharmaceuticals Oral Diuretic Drugs Product Portfolios and Specifications
13.11.3 Novartis Pharmaceuticals Oral Diuretic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Novartis Pharmaceuticals Main Business Overview
13.11.5 Novartis Pharmaceuticals Latest Developments
13.12 Pfizer
13.12.1 Pfizer Company Information
13.12.2 Pfizer Oral Diuretic Drugs Product Portfolios and Specifications
13.12.3 Pfizer Oral Diuretic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Pfizer Main Business Overview
13.12.5 Pfizer Latest Developments
13.13 Sanofi
13.13.1 Sanofi Company Information
13.13.2 Sanofi Oral Diuretic Drugs Product Portfolios and Specifications
13.13.3 Sanofi Oral Diuretic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Sanofi Main Business Overview
13.13.5 Sanofi Latest Developments
13.14 Teva Pharmaceutical Industries
13.14.1 Teva Pharmaceutical Industries Company Information
13.14.2 Teva Pharmaceutical Industries Oral Diuretic Drugs Product Portfolios and Specifications
13.14.3 Teva Pharmaceutical Industries Oral Diuretic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Teva Pharmaceutical Industries Main Business Overview
13.14.5 Teva Pharmaceutical Industries Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Oral Diuretic Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Oral Diuretic Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Loop Diuretics
Table 4. Major Players of Thiazides and Thiazide-Like Diuretics
Table 5. Major Players of Carbonic Anhydrase Inhibitors
Table 6. Major Players of Potassium-Sparing Diuretics
Table 7. Major Players of Osmotic Diuretics
Table 8. Global Oral Diuretic Drugs Sales by Type (2018-2023) & (K Units)
Table 9. Global Oral Diuretic Drugs Sales Market Share by Type (2018-2023)
Table 10. Global Oral Diuretic Drugs Revenue by Type (2018-2023) & ($ million)
Table 11. Global Oral Diuretic Drugs Revenue Market Share by Type (2018-2023)
Table 12. Global Oral Diuretic Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Oral Diuretic Drugs Sales by Application (2018-2023) & (K Units)
Table 14. Global Oral Diuretic Drugs Sales Market Share by Application (2018-2023)
Table 15. Global Oral Diuretic Drugs Revenue by Application (2018-2023)
Table 16. Global Oral Diuretic Drugs Revenue Market Share by Application (2018-2023)
Table 17. Global Oral Diuretic Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Oral Diuretic Drugs Sales by Company (2018-2023) & (K Units)
Table 19. Global Oral Diuretic Drugs Sales Market Share by Company (2018-2023)
Table 20. Global Oral Diuretic Drugs Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Oral Diuretic Drugs Revenue Market Share by Company (2018-2023)
Table 22. Global Oral Diuretic Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Oral Diuretic Drugs Producing Area Distribution and Sales Area
Table 24. Players Oral Diuretic Drugs Products Offered
Table 25. Oral Diuretic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Oral Diuretic Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Oral Diuretic Drugs Sales Market Share Geographic Region (2018-2023)
Table 30. Global Oral Diuretic Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Oral Diuretic Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Oral Diuretic Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Oral Diuretic Drugs Sales Market Share by Country/Region (2018-2023)
Table 34. Global Oral Diuretic Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Oral Diuretic Drugs Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Oral Diuretic Drugs Sales by Country (2018-2023) & (K Units)
Table 37. Americas Oral Diuretic Drugs Sales Market Share by Country (2018-2023)
Table 38. Americas Oral Diuretic Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Oral Diuretic Drugs Revenue Market Share by Country (2018-2023)
Table 40. Americas Oral Diuretic Drugs Sales by Type (2018-2023) & (K Units)
Table 41. Americas Oral Diuretic Drugs Sales by Application (2018-2023) & (K Units)
Table 42. APAC Oral Diuretic Drugs Sales by Region (2018-2023) & (K Units)
Table 43. APAC Oral Diuretic Drugs Sales Market Share by Region (2018-2023)
Table 44. APAC Oral Diuretic Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Oral Diuretic Drugs Revenue Market Share by Region (2018-2023)
Table 46. APAC Oral Diuretic Drugs Sales by Type (2018-2023) & (K Units)
Table 47. APAC Oral Diuretic Drugs Sales by Application (2018-2023) & (K Units)
Table 48. Europe Oral Diuretic Drugs Sales by Country (2018-2023) & (K Units)
Table 49. Europe Oral Diuretic Drugs Sales Market Share by Country (2018-2023)
Table 50. Europe Oral Diuretic Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Oral Diuretic Drugs Revenue Market Share by Country (2018-2023)
Table 52. Europe Oral Diuretic Drugs Sales by Type (2018-2023) & (K Units)
Table 53. Europe Oral Diuretic Drugs Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Oral Diuretic Drugs Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Oral Diuretic Drugs Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Oral Diuretic Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Oral Diuretic Drugs Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Oral Diuretic Drugs Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Oral Diuretic Drugs Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Oral Diuretic Drugs
Table 61. Key Market Challenges & Risks of Oral Diuretic Drugs
Table 62. Key Industry Trends of Oral Diuretic Drugs
Table 63. Oral Diuretic Drugs Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Oral Diuretic Drugs Distributors List
Table 66. Oral Diuretic Drugs Customer List
Table 67. Global Oral Diuretic Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Oral Diuretic Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Oral Diuretic Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Oral Diuretic Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Oral Diuretic Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Oral Diuretic Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Oral Diuretic Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Oral Diuretic Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Oral Diuretic Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Oral Diuretic Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Oral Diuretic Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Oral Diuretic Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Oral Diuretic Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Oral Diuretic Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. AstraZeneca Basic Information, Oral Diuretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 82. AstraZeneca Oral Diuretic Drugs Product Portfolios and Specifications
Table 83. AstraZeneca Oral Diuretic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. AstraZeneca Main Business
Table 85. AstraZeneca Latest Developments
Table 86. Aurobindo Pharma Basic Information, Oral Diuretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 87. Aurobindo Pharma Oral Diuretic Drugs Product Portfolios and Specifications
Table 88. Aurobindo Pharma Oral Diuretic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Aurobindo Pharma Main Business
Table 90. Aurobindo Pharma Latest Developments
Table 91. Bayer AG Basic Information, Oral Diuretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 92. Bayer AG Oral Diuretic Drugs Product Portfolios and Specifications
Table 93. Bayer AG Oral Diuretic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Bayer AG Main Business
Table 95. Bayer AG Latest Developments
Table 96. Bristol-Myers Squibb Company Basic Information, Oral Diuretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Bristol-Myers Squibb Company Oral Diuretic Drugs Product Portfolios and Specifications
Table 98. Bristol-Myers Squibb Company Oral Diuretic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Bristol-Myers Squibb Company Main Business
Table 100. Bristol-Myers Squibb Company Latest Developments
Table 101. Cipla Ltd Basic Information, Oral Diuretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Cipla Ltd Oral Diuretic Drugs Product Portfolios and Specifications
Table 103. Cipla Ltd Oral Diuretic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Cipla Ltd Main Business
Table 105. Cipla Ltd Latest Developments
Table 106. F. Hoffmann-La Roche Basic Information, Oral Diuretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. F. Hoffmann-La Roche Oral Diuretic Drugs Product Portfolios and Specifications
Table 108. F. Hoffmann-La Roche Oral Diuretic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. F. Hoffmann-La Roche Main Business
Table 110. F. Hoffmann-La Roche Latest Developments
Table 111. Fresenius Kabi Basic Information, Oral Diuretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. Fresenius Kabi Oral Diuretic Drugs Product Portfolios and Specifications
Table 113. Fresenius Kabi Oral Diuretic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Fresenius Kabi Main Business
Table 115. Fresenius Kabi Latest Developments
Table 116. GSK Basic Information, Oral Diuretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. GSK Oral Diuretic Drugs Product Portfolios and Specifications
Table 118. GSK Oral Diuretic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. GSK Main Business
Table 120. GSK Latest Developments
Table 121. Hikma Pharmaceuticals Basic Information, Oral Diuretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. Hikma Pharmaceuticals Oral Diuretic Drugs Product Portfolios and Specifications
Table 123. Hikma Pharmaceuticals Oral Diuretic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Hikma Pharmaceuticals Main Business
Table 125. Hikma Pharmaceuticals Latest Developments
Table 126. Mylan Basic Information, Oral Diuretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. Mylan Oral Diuretic Drugs Product Portfolios and Specifications
Table 128. Mylan Oral Diuretic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Mylan Main Business
Table 130. Mylan Latest Developments
Table 131. Novartis Pharmaceuticals Basic Information, Oral Diuretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 132. Novartis Pharmaceuticals Oral Diuretic Drugs Product Portfolios and Specifications
Table 133. Novartis Pharmaceuticals Oral Diuretic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Novartis Pharmaceuticals Main Business
Table 135. Novartis Pharmaceuticals Latest Developments
Table 136. Pfizer Basic Information, Oral Diuretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 137. Pfizer Oral Diuretic Drugs Product Portfolios and Specifications
Table 138. Pfizer Oral Diuretic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. Pfizer Main Business
Table 140. Pfizer Latest Developments
Table 141. Sanofi Basic Information, Oral Diuretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 142. Sanofi Oral Diuretic Drugs Product Portfolios and Specifications
Table 143. Sanofi Oral Diuretic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. Sanofi Main Business
Table 145. Sanofi Latest Developments
Table 146. Teva Pharmaceutical Industries Basic Information, Oral Diuretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 147. Teva Pharmaceutical Industries Oral Diuretic Drugs Product Portfolios and Specifications
Table 148. Teva Pharmaceutical Industries Oral Diuretic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 149. Teva Pharmaceutical Industries Main Business
Table 150. Teva Pharmaceutical Industries Latest Developments
List of Figures
Figure 1. Picture of Oral Diuretic Drugs
Figure 2. Oral Diuretic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Diuretic Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Oral Diuretic Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Oral Diuretic Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Loop Diuretics
Figure 10. Product Picture of Thiazides and Thiazide-Like Diuretics
Figure 11. Product Picture of Carbonic Anhydrase Inhibitors
Figure 12. Product Picture of Potassium-Sparing Diuretics
Figure 13. Product Picture of Osmotic Diuretics
Figure 14. Global Oral Diuretic Drugs Sales Market Share by Type in 2022
Figure 15. Global Oral Diuretic Drugs Revenue Market Share by Type (2018-2023)
Figure 16. Oral Diuretic Drugs Consumed in Hospital Pharmacies
Figure 17. Global Oral Diuretic Drugs Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 18. Oral Diuretic Drugs Consumed in Retail Pharmacies
Figure 19. Global Oral Diuretic Drugs Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 20. Oral Diuretic Drugs Consumed in Online Pharmacies
Figure 21. Global Oral Diuretic Drugs Market: Online Pharmacies (2018-2023) & (K Units)
Figure 22. Global Oral Diuretic Drugs Sales Market Share by Application (2022)
Figure 23. Global Oral Diuretic Drugs Revenue Market Share by Application in 2022
Figure 24. Oral Diuretic Drugs Sales Market by Company in 2022 (K Units)
Figure 25. Global Oral Diuretic Drugs Sales Market Share by Company in 2022
Figure 26. Oral Diuretic Drugs Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Oral Diuretic Drugs Revenue Market Share by Company in 2022
Figure 28. Global Oral Diuretic Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Oral Diuretic Drugs Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Oral Diuretic Drugs Sales 2018-2023 (K Units)
Figure 31. Americas Oral Diuretic Drugs Revenue 2018-2023 ($ Millions)
Figure 32. APAC Oral Diuretic Drugs Sales 2018-2023 (K Units)
Figure 33. APAC Oral Diuretic Drugs Revenue 2018-2023 ($ Millions)
Figure 34. Europe Oral Diuretic Drugs Sales 2018-2023 (K Units)
Figure 35. Europe Oral Diuretic Drugs Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Oral Diuretic Drugs Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Oral Diuretic Drugs Revenue 2018-2023 ($ Millions)
Figure 38. Americas Oral Diuretic Drugs Sales Market Share by Country in 2022
Figure 39. Americas Oral Diuretic Drugs Revenue Market Share by Country in 2022
Figure 40. Americas Oral Diuretic Drugs Sales Market Share by Type (2018-2023)
Figure 41. Americas Oral Diuretic Drugs Sales Market Share by Application (2018-2023)
Figure 42. United States Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Oral Diuretic Drugs Sales Market Share by Region in 2022
Figure 47. APAC Oral Diuretic Drugs Revenue Market Share by Regions in 2022
Figure 48. APAC Oral Diuretic Drugs Sales Market Share by Type (2018-2023)
Figure 49. APAC Oral Diuretic Drugs Sales Market Share by Application (2018-2023)
Figure 50. China Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Oral Diuretic Drugs Sales Market Share by Country in 2022
Figure 58. Europe Oral Diuretic Drugs Revenue Market Share by Country in 2022
Figure 59. Europe Oral Diuretic Drugs Sales Market Share by Type (2018-2023)
Figure 60. Europe Oral Diuretic Drugs Sales Market Share by Application (2018-2023)
Figure 61. Germany Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Oral Diuretic Drugs Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Oral Diuretic Drugs Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Oral Diuretic Drugs Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Oral Diuretic Drugs Sales Market Share by Application (2018-2023)
Figure 70. Egypt Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Oral Diuretic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Oral Diuretic Drugs in 2022
Figure 76. Manufacturing Process Analysis of Oral Diuretic Drugs
Figure 77. Industry Chain Structure of Oral Diuretic Drugs
Figure 78. Channels of Distribution
Figure 79. Global Oral Diuretic Drugs Sales Market Forecast by Region (2024-2029)
Figure 80. Global Oral Diuretic Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Oral Diuretic Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Oral Diuretic Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Oral Diuretic Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Oral Diuretic Drugs Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の経口利尿薬市場予測 2023年-2029年] (コード：LP23DC06150)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の経口利尿薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のリスペリドン経口液市場予測 2023年-2029年
  • 世界のヨウ素ナトリウム（131I）薬剤市場予測 2023年-2029年
  • 世界の動物用サルファ剤市場予測 2023年-2029年
  • 世界の口腔外科用ロボット市場予測 2023年-2029年
  • 世界の経口腸チフスワクチン市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆